Achondroplasia in children
| Achondroplasia in children | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Short stature, disproportionate dwarfism, macrocephaly, midface hypoplasia |
| Complications | Spinal stenosis, obstructive sleep apnea, ear infections, hydrocephalus |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the FGFR3 gene |
| Risks | Advanced paternal age |
| Diagnosis | Physical examination, genetic testing |
| Differential diagnosis | Hypochondroplasia, thanatophoric dysplasia, pseudoachondroplasia |
| Prevention | None |
| Treatment | Growth hormone therapy, surgical intervention |
| Medication | Vosoritide |
| Prognosis | Generally good with management |
| Frequency | 1 in 15,000 to 40,000 live births |
| Deaths | Rare, usually related to complications |
Achondroplasia is a genetic disorder that is a common cause of dwarfism. It affects the growth of bones, leading to a characteristic appearance that includes a short stature, disproportionately short arms and legs, a large head with a prominent forehead, and a flattened bridge of the nose. This article focuses on achondroplasia as it presents in children, including its causes, diagnosis, and management.
Causes[edit]
Achondroplasia is caused by a mutation in the FGFR3 gene (Fibroblast Growth Factor Receptor 3). This gene is crucial for the development and maintenance of bone and brain tissue. In achondroplasia, the mutation leads to an abnormal version of the FGFR3 protein, which interferes with the normal growth of cartilage into bone, particularly in the long bones of the arms and legs. The condition is inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is sufficient to cause the disorder. However, most cases (about 80%) arise from new mutations in the gene and occur in families with no history of the condition.
Symptoms and Characteristics[edit]
Children with achondroplasia exhibit a number of distinctive physical features and health issues. These include:
- Short stature, with an adult height around 4 feet (122 cm) for both males and females.
- Disproportionately short limbs, especially the upper arms and thighs.
- A large head with a prominent forehead and a flattened nasal bridge.
- Spinal abnormalities such as lordosis (swayback) or kyphosis (hunchback).
- Frequent middle ear infections, which can lead to hearing loss.
- Breathing problems due to a small chest and issues with the upper airways.
Diagnosis[edit]
Diagnosis of achondroplasia in children can often be made based on physical characteristics and family history. Prenatal ultrasound can sometimes detect signs of the condition in the fetus. After birth, a definitive diagnosis is usually made through genetic testing to identify the mutation in the FGFR3 gene.
Management and Treatment[edit]
There is no cure for achondroplasia, but treatments are available to manage symptoms and prevent or address complications. Management strategies include:
- Monitoring and treating ear infections promptly to prevent hearing loss.
- Physical therapy to strengthen muscles and improve mobility.
- Orthopedic interventions, such as surgery, to correct bone abnormalities if necessary.
- Growth hormone therapy, which has been used in some cases to increase height, though its effectiveness is still under study.
- Supportive therapies to address breathing problems and sleep apnea.
Living with Achondroplasia[edit]
Children with achondroplasia can lead healthy, active lives with proper medical care and support. It is important for parents and caregivers to foster a positive self-image in the child and to educate them about their condition in an age-appropriate manner. Support groups and organizations for individuals with dwarfism can provide valuable resources and a sense of community.
Conclusion[edit]
Achondroplasia in children presents unique challenges, but with early diagnosis, comprehensive management, and supportive care, these children can grow up to lead fulfilling lives. Ongoing research into treatments and interventions offers hope for even better outcomes in the future.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
